Conclusion Clinical trial data from large, controlled studies demonstrate the efficacy and safety of GLP-1 agonists in terms of A1C reduction, beneficial effects on body weight, and a low risk for hypoglycemic events when used as monotherapy
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, and did not provide support in the form of salaries for any authors
39 Our finding indicates that GABA-glutamate metabolism is indeed in a state of imbalance in the striatum of SD rats in the TS model
However, like creatines side effects, these are rare and affect very few people
Bottom Line Ipamorelin and GHRP-2 are both growth hormone secretagogues, but they are different tools in research discussions